George Yancopoulos, President Regeneron Laboratori at REGENERON PHARMACEUTICALS INC (REGN), sold 203,243 shares at $263.22 ($53.2M) on 2013-05-07, disclosed to the SEC on 2013-05-08.
Open-market sale of $53.2M REGN by President Regeneron Laboratori. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $260.44 | 9,599 | $2.5M | 4.7% |
| 2 | $260.44 | 93,644 | $24.4M | 45.9% |
| 3 | $261.66 | 13,457 | $3.5M | 6.6% |
| 4 | $262.43 | 47,876 | $12.6M | 23.6% |
| 5 | $263.22 | 38,267 | $10.1M | 19.0% |
| 6 | $264.21 | 400 |
| $106K |
| 0.2% |
| Total | $261.52 avg | 203,243 | $53.2M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |